Intravenous nutrition is regarded as one of the most significant advances in medical and surgical management during the past 20 years. Several studies have documented a high incidence of clinical and sub clinical malnutrition in hospitalised patients,1' 2 which is associated with increased morbidity and mortality. These complications of medical and surgical disease may be reduced by the appropriate provision of nutritional support by oral, enteral, or parenteral route. The therapeutic nutritional regimen should provide adequate protein and energy substrates to replete and maintain adequate nutrition and to match the increased metabolic demands of illness and infection.3 The formulation of an intravenous regimen is based on the use of solutions containing essential and non -essential crystalline amino acids to provide protein requirements, the use of carbohydrate solutions or fat emulsions or a combination of both to provide energy, and the addition of minerals, vitamins, and trace elements to satisfy daily requirements. Although a standardised regimen containing about equal proportions of crystalline amino acids and dextrose with appropriate additives will satisfy the nutritional requirements of many patients, adjustments may be needed to meet the increased demand for all nutrients during infection, or to cope with special problems such as renal failure, hepatic dysfunction, protein intolerance and the paediatric patient.3 Controversy exists concerning both the composition of amino acid solutions, and the most appropriate energy source for optimal utilisation in various diseases. This review discusses the use of hypertonic glucose solutions, glucose substitutes, and fat emulsions as energy sources in intravenous
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ENERGY REQUIREMENTS
The relative energy requirements in health and disease differ. The basal energy expenditure of a normal 70kg man at rest is about 2,000 Kcal per day. Decreased food intake is accompanied by weight loss and a decrease in basal energy expenditure. Following elective surgical procedures, in the absence of significant complications, the post-operative energy expenditure will not ordinarily differ by more than 10% from pre-operative values. Previously well-nourished patients with multiple fractures may have an increase in basal energy expenditure of 10 -25 %, and in major infection, such as intra -abdominal abscess or peritonitis, there may be an increase of up to 50-75% above predicted normal levels.
Sustained higher levels of basal energy expenditure (125%) may occur with major thermal burns. The metabolic response to injury is classically described as being separated into two distinct phases -an acute phase in which there is mobilisation of endogenous substrates to provide energy, and an adaptive phase in which metabolism is dependent on the availability of nutrient substrates. These phases correspond to the 'ebb' and 'flow' phases of the metabolic response to trauma originally described by Cuthbertson in 1942.4 The metabolic response to starvation differs from that of injury and infection, and it is important to realise that, in individual patients, varying degrees of starvation, injury, and infection may contribute to the overall changes in hormonal and substrate homoeostasis.
METABOLIC RESPONSE TO STARVATION
The sequence of events leading to death in starvation is usually decreased food intake, protein wasting, weakness of respiratory muscles, atelectasis, pneumonia, and death. The metabolic response to starvation has an initial and a late phase: the initial phase is directed toward maintaining glucose production to meet the needs of the brain, nervous tissue, and red blood cells (gluconeogenic phase), and the late phase toward minimising the rate of protein breakdown (proteinconservation phase). Fat in glucose utilisation. These changes are accompanied by an increase in circulating ketone bodies, which are formed from fatty acids in the liver. There is a reduced need for gluconeogenesis which is reflected in a decreased output of alanine from muscle.
METABOLIC RESPONSE TO INJURY AND INFECTION
Following the stress of injury or infection, the pattern of endogenous fuel substrate utilisation differs from that observed in uncomplicated starvation. The most obvious differences are protein wastage, hyperglycaemia, and anaerobic glycolysis with lactate production. Injury induces a wide range of integrated changes in haemodynamics, neuroendocrine secretions (in particular, insulin, glucagon, corticosteroids, and catecholamines), and tissue metabolism. Provided that the injury is not fatal, the immediate phase of depressed local metabolism is followed by a period of increased general metabolism due to the increased cellular activity of the repair process, elimination of damaged and devitalised tissue, and increased catabolism of protein. There is also increased oxygen consumption and heat production, and the increased nitrogen excretion closely parallels the increased energy expenditure. The changes in energy metabolism are most important for survival and repair. There is increased sympathetic activity for 48-72 hours which ensures an adequate mobilisation of carbohydrate and fat stores, resulting in hyperglycaemia and increased plasma non -esterified fatty acids, but the rates of oxidation of both substrates are unaltered. Following the acute reaction to injury, which may last up to 72 hours, there is an increase in heat production and rise in body temperature associated with an increase in urinary excretion of nitrogen, inorganic sulphate, phosphate, potassium, and creatinine. The excess nitrogen is derived from catabolism of muscle protein and the oxidation of non-nitrogenous residues accounts for some of the extra heat production. This obligatory protein loss cannot be completely abolished in the immediate post-traumatic period, even with large intake of protein and calories. Protein catabolism is accelerated to a greater extent than protein anabolism and the prolonged proteolysis of muscle protein leads to excessive hepatic gluconeogenesis, depletion of muscle protein, weakness, reduction of protein synthesis, diminished enzyme function, and loss of immunocompetence. Hyperglycaemia and a diabetic glucose-tolerance curve are characteristic of the response to injury and infection, despite a normal insulin response to hyperglycaemia. Glucose uptake by the tissues is unaltered, suggesting insulin resistance in the tissues. Adipose tissue still responds to hyperinsulinaemia by suppression of lipolysis. Alanine, lactate, and glycerol all provide an increasing flow of gluconeogenic substrate to the liver which releases more glucose under the influence of alanine-induced hyperglucagonaemia. There may be impairment of uptake of other metabolic fuels (non-esterified fatty acids, ketone bodies) leading to the oxidation of branched-chain amino acids derived from muscle protein to satisfy the local energy requirements of muscle. Thus, hyperglycaemia reflects an augmentation of the glucose pool to maintain glucose oxidation rates rather than a need for overall energy provision from proteolysis. Although the nitrogen excretion following injury parallels the increased resting metabolic expenditure and weight loss, the energy contribution of protein is only about 20 % of daily expenditure, the residual energy requirement being met by mobilisation of fat stores. Glucose infusion stimulates insulin production from the pancreas which enhances protein anabolism and reduces proteolysis and gluconeogenesis. In many patients, glucose may be used as the sole energy source. The disadvantages of glucose as an intravenous energy source are usually related to two factors -firstly, the supply of glucose in excess of the energy requirements, and, secondly, changes in body metabolism as a result of injury and infection which interfere with the cellular metabolism of glucose. These conditions may produce hyperglycaemia and osmotic diuresis leading to fluid, electrolyte, and acid-base imbalance and requiring the use of exogenous insulin to maintain normoglycaemia. Excessive intravenous glucose may also lead to impairment of biochemical liver function tests, increased fat synthesis and deposition, hypophosphataemia, and increased C02 production. Due to the hypertonicity of the solutions, central venous thrombosis may occur and bacterial contamination with septicaemia is common unless a strict protocol is followed for the management of central venous lines. Infusion regimens that contain no fat will lead to essential fatty acid deficiency after several weeks. Concentrated glucose infusions should always be given with an adequate protein intake to avoid the development of 'iatrogenic kwashiorkor'. The energy requirements in starvation and nutritional depletion without stress are relatively easily supplied by glucose infusion alone. However, there is an upper i The Ulster Medical Society, 1987. limit to the rate of glucose oxidation, and endogenous fat continues to be used for a portion of the total energy requirements.5 Excess glucose is converted to fat which is inefficient as lipogenesis consumes energy that is not recovered during subsequent lipolysis. In mild and moderate stress, there is usually hyperglycaemia due to increased gluconeogenesis rather than reduced glucose oxidation.6 Glucose infusion will not completely abolish gluconeogenesis and fat oxidation and mobilisation of endogenous fat continues even when glucose is supplied in quantities that satisfy energy requirements. Large glucose loads may also decrease free fatty acid oxidation and cause additional stress by increasing oxygen consumption and carbon dioxide production and norepinephrine excretion in the urine.7 Intolerance to glucose may be even more pronounced in the severely stressed critically ill patient and large quantities of exogenous insulin may be required. Intravenous regimens containing crystalline amino acids and glucose as the nonprotein energy source have been shown to improve nitrogen balance in a number of disease states and clinical situations.8 9, 10 The weight of evidence from clinical studies shows that, with adequate protein intake, nitrogen retention and utilisation improves as energy intake increases, until energy requirements are satisfied.IO 11 Energy supply in excess of requirements produces no additional nitrogen sparing and may give rise to significant biochemical, hepatic, and respiratory complications.8 12 
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